Event

WEBINAR: "The Access to Medicines Index (AtMI): Catalyst for Change or Barrier to Access?"

This webinar launched the publication, "Corporate accountability in global health governance? A case study of the Access to Medicine Index"

Time
- Asia/Kuala Lumpur

The Access to Medicine Index (AtMI) is an instrument that measures the performance of the 20 biggest pharmaceutical TNCs in terms of how they contribute to improving access to medicines and other products in L&MICs. This measure is used to rank the corporations which is expected to incentivise pharma companies to compete with each other by improving their policies and practices to improve access to medicines in L&MICs.

The AtMI is well funded and generally celebrated as a successful initiative that catalyses corporate social responsibility and helps improve global health.

But is the AtMI really effective? Or does it actually serve to maintain the power and excessive profitability of Big Pharma? 

A discussion was held on 17 October to critically interrogate the use of the "league table" as an accountability mechanism to improve access to medicines, and explore why such mechanisms might paradoxically weaken efforts to regulate pharmaceutical companies.

Revisit the webinar here: https://go.unu.edu/a4VE2 

 

Related content

Article

Background Papers for the Global Health Symposium

Background readings provided to inform Global Health Symposium discussions on governance, accountability, and power in global health.

01 Aug 2025

Project

Role of Participation in Achieving Sustainable and Resilient Agri-food Systems in Face of Emerging External Shocks: A Coupled Citizen Science and Nature-based Solutions Approach (CS-NbS)

This project will contribute to recommending a governance structure that helps achieve a sustainable and resilient agri-food system.

24 Jul 2025